Data Driven Utilization Management, Purpose Built for Oncology

Oncology Analytics® provides health plans, providers, and patients with a data-driven, utilization management solution that delivers real-world, evidence-based analytics focused exclusively for oncology

Learn More

A Patient-First Approach to Cancer Care

Learn more about Oncology Analytics’ mission to ensure that all patients receive the best possible evidence-based treatment, tailored to their unique personal needs

Watch the Video

FDA Oncology Drug Approvals

Q4 - 2020

Download the report

Cancer care is rapidly evolving as new delivery methods and treatment options come online at an aggressive daily pace. The growing number of treatment options, combinations, and additional lines of therapy simultaneously increase the complexity in making an evidence-based determination for how to treat a patient’s cancer.

Bringing together science, technology and analytics to support evidence-based decision-making in oncology utilization management addresses the two biggest challenges associated with making informed and timely patient treatment decisions: speed and evidence. This type of approach requires deep analytics and insights into a health plan’s cancer drug spend to ensure that anti-cancer therapies are based on science and evidence-based protocols specific to the patient’s unique circumstances and needs.

Oncology Analytics is a different kind of partner for oncology utilization management. We provide access to current, evidence-based, disease-specific analytics on all cancer types and treatment options, backed by board-certified oncology physicians and pharmacists. Our data science teams utilize advanced data models and machine learning to better understand outcomes in all areas of cancer treatment and ensure that your members receive the right treatment at the right time and the right cost. Our comprehensive approach to real-world data and analytics is based on the organization and normalization of clinical data, such as EMR progress notes, pathology and lab reports, biomarker data, histology, and cancer stage. Clinical data is then combined with claims data to provide unique insights and benchmarks focused on health plans’ oncology spend, trend, and provider network performance.

Join the conversation

Subscribe to our newsletter

Solutions

Oncology Analytics offers critical technology and services that address the primary challenges and gaps health plans face in advancing a data-driven strategy for oncology utilization management:

OneUM™

A cross-benefit utilization management platform that encompasses both medical benefit and pharmacy benefit oncology drugs. With OneUM, treating oncology providers can use the latest in secure, cloud-based technology to submit a single e-Prior Authorization request for all oncology drug requests, since the platform includes treatment regimens that span both benefit types. This technology-enabled service speeds the complete review process and eliminates manual faxing and phone calls.
Read More

Oncology Insights Pro™

An analytics software solution that enables health plans and other risk-bearing entities to use data and analytics to improve oncology programs, as the costs and organizational importance of cancer care continue to increase. Oncology Insights Pro is unique compared to other healthcare analytics solutions by focusing on three key elements: real-world data, comparative benchmarking, and advisory services.
Read More

Pharmacy Consulting

A highly focused group of experienced and board-certified oncology pharmacy professionals, who partner with health plans to keep them up to date on the rapidly changing cancer therapy landscape to improve member care and ensure proper financial impact for the health plan.
Read More

News

Harvard Pilgrim Health Care Partners With Oncology Analytics for Oncology Benefits Management

Harvard Pilgrim Implements Real-World Data-Driven Prior Authorization Solution That Leverages Both Clinical and Claims Data

Oncology Analytics Launches Pharmacy Consulting Services

New Offering Designed to Help Health Plans Navigate the Anti-Cancer Drug Market to Improve Member Treatment Recommendations

« Older Entries

Articles & Press

Breast Cancer Care: Zooming through 2020

As coronavirus disease 2019 (COVID-19) has transformed the world we live in, so too has it changed the paradigms of treatment for many cancers.

#1 Put the Patient First

The following article is the fifth in a five-part series on The Top Five Ways for Health Plans to Manage Oncology Drug Costs While Improving Member Treatment Options.

« Older Entries